Fox, Robert J.

Defining the clinical course of multiple sclerosis: The 2013 revisions

Lublin, F. D., Reingold, S. C., Cohen, J. A., Cutter, G. R., Sørensen, P. S., Thompson, A. J., Wolinsky, J. S., Balcer, L. J., Banwell, B., Barkhof, F., et al. (2014) · Neurology

Multiple Sclerosis Research StudiesPsoriasis: Treatment and Pathogenesis

Cited by 3,177

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

Hauser, S. L., Waubant, E., Arnold, D. L., Vollmer, T., Antel, J., Fox, R. J., Bar-Or, A., Panzara, M., Sarkar, N., Agarwal, S., et al. (2008) · New England Journal of Medicine

Multiple Sclerosis Research StudiesPolyomavirus and related diseases

Cited by 2,439

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Kappos, L., Bar-Or, A., Cree, B. A. C., Fox, R. J., Giovannoni, G., Gold, R., Vermersch, P., Arnold, D. L., Arnould, S., Scherz, T., et al. (2018) · The Lancet

Multiple Sclerosis Research StudiesSphingolipid Metabolism and Signaling

Cited by 942

Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function

Ontaneda, D., Thompson, A. J., Fox, R. J., & Cohen, J. A. (2017) · The Lancet

Multiple Sclerosis Research StudiesPsoriasis: Treatment and Pathogenesis

Cited by 298

Multiple sclerosis normal‐appearing white matter: Pathology–imaging correlations

Moll, N. M., Rietsch, A. M., Thomas, S., Ransohoff, A. J., Lee, J., Fox, R., Chang, A., Ransohoff, R. M., & Fisher, E. (2011) · Annals of Neurology

Multiple Sclerosis Research StudiesAdvanced Neuroimaging Techniques and Applications

Cited by 297

Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study: A Randomized Clinical Trial

Kappos, L., Fox, R. J., Burcklen, M., Freedman, M. S., Havrdová, E. K., Hennessy, B., Hohlfeld, R., Lublin, F., Montalban, X., Pozzilli, C., et al. (2021) · JAMA Neurology

Multiple Sclerosis Research StudiesSphingolipid Metabolism and Signaling

Cited by 228

Cortical remyelination: A new target for repair therapies in multiple sclerosis

Chang, A., Staugaitis, S. M., Dutta, R., Batt, C. E., Easley, K. E., Chomyk, A. M., Yong, V. W., Fox, R. J., Kidd, G. J., & Trapp, B. D. (2012) · Annals of Neurology

Multiple Sclerosis Research StudiesNeurogenesis and neuroplasticity mechanisms

Cited by 216

Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: A phase 2b, randomised, double-blind, placebo-controlled trial

Reich, D. S., Arnold, D. L., Vermersch, P., Bar-Or, A., Fox, R. J., Matta, A., Turner, T., Wallström, E., Zhang, X., Mareš, M., et al. (2021) · The Lancet Neurology

Multiple Sclerosis Research StudiesChronic Lymphocytic Leukemia Research

Cited by 204

Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: A retrospective study

Trapp, B. D., Vignos, M., Dudman, J., Chang, A., Fisher, E., Staugaitis, S. M., Battapady, H., Mork, S., Ontaneda, D., Jones, S. E., et al. (2018) · The Lancet Neurology

Multiple Sclerosis Research StudiesNeuroinflammation and Neurodegeneration Mechanisms

Cited by 146

Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis

Fox, R. J., Bar-Or, A., Traboulsee, A., Oreja-Guevara, C., Giovannoni, G., Vermersch, P., Syed, S., Li, Y., Vargas, W. S., Turner, T. J., et al. (2025) · New England Journal of Medicine

Multiple Sclerosis Research StudiesChronic Lymphocytic Leukemia Research

Cited by 146

A validation study of multicenter diffusion tensor imaging: Reliability of fractional anisotropy and diffusivity values

Fox, R. J., Sakaie, K., Lee, J.-C., Debbins, J. P., Liu, Y., Arnold, D. L., Melhem, E. R., Smith, C. H., Philips, M. D., Lowe, M., et al. (2012) · American Journal of Neuroradiology

Advanced Neuroimaging Techniques and ApplicationsAdvanced MRI Techniques and Applications

Cited by 137

BG-12 (dimethyl fumarate): a review of mechanism of action, efficacy, and safety

Fox, R. J., Kita, M., Cohan, S. L., Henson, L. J., Zambrano, J., Scannevin, R. H., O'Gorman, J., Novas, M., Dawson, K. T., & Phillips, J. T. (2014) · Current Medical Research and Opinion

Multiple Sclerosis Research StudiesPsoriasis: Treatment and Pathogenesis

Cited by 124

Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial

Vermersch, P., Brieva-Ruiz, L., Fox, R. J., Paul, F., Ramio-Torrenta, L., Schwab, M., Moussy, A., Mansfield, C., Hermine, O., Maciejowski, M., et al. (2022) · Neurology Neuroimmunology & Neuroinflammation

Multiple Sclerosis Research StudiesPolyomavirus and related diseases

Cited by 74

Diagnosing multiple sclerosis at a later age: more than just progressive myelopathy

Bermel, R. A., Rae-Grant, A. D., & Fox, R. J. (2010) · Multiple Sclerosis Journal

Multiple Sclerosis Research StudiesPolyomavirus and related diseases

Cited by 46